Tuis4142 • TPE
add
Adimmune Corp
Vorige sluiting
NT$18,95
Dagwisseling
NT$18,80 - NT$19,10
Jaarwisseling
NT$15,90 - NT$27,00
Markkapitalisasie
8,14 mjd TWD
Gemiddelde volume
1,67 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
TPE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (TWD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 475,32 m | -46,49% |
Bedryfskoste | 146,27 m | -14,74% |
Netto inkomste | -18,26 m | -106,93% |
Netto winsgrens | -3,84 | -112,96% |
Wins per aandeel | — | — |
EBITDA | -19,68 m | -106,24% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (TWD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,79 mjd | -3,29% |
Totale bates | 8,38 mjd | -2,80% |
Totale aanspreeklikheid | 3,53 mjd | 18,40% |
Totale ekwiteit | 4,85 mjd | — |
Uitstaande aandele | 421,51 m | — |
Prys om te bespreek | 1,69 | — |
Opbrengs op bates | -1,86% | — |
Opbrengs op kapitaal | -1,94% | — |
Kontantvloei
Netto kontantverandering
| (TWD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -18,26 m | -106,93% |
Kontant van bedrywe | -355,08 m | -17,80% |
Kontant van beleggings | -173,61 m | -102,13% |
Kontant van finansiering | 403,21 m | 5 593,35% |
Netto kontantverandering | -117,89 m | 70,35% |
Beskikbare kontantvloei | -460,83 m | -29,17% |
Meer oor
Adimmune Corporation is a Taiwanese biopharmaceutical company headquartered in Taichung. Originally founded in 1965 as Taiwan’s first vaccine laboratory, it later evolved into a modern vaccine manufacturer and contract development and manufacturing organization. The company is notable for being the only influenza vaccine manufacturer in Asia certified by both the European Union Good Manufacturing Practice and the U.S. Food and Drug Administration, and the*only human vaccine manufacturer in Taiwan operating under PIC/S GMP standards. Wikipedia
Gestig
1965
Webwerf
Werknemers
564
